Articles tagged with Cancer Medication
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study reveals the link between obesity and increased risk of myeloma, a cancer of plasma cells. The researchers found that adiponectin, a protective protein, can be used to suppress fatty acid production in myeloma cells, leading to their demise.
Researchers at Georgetown University Medical Center have identified Yes-associated protein (Yes) as the critical switch that promotes cancer growth and progression in pancreatic ductal adenocarcinoma (PDAC). Inhibiting Yes completely shuts down further growth of pancreatic cancer, offering a promising therapeutic target.
Advances in biological imaging enable scientists to identify the most promising new drugs and rule out those unlikely to work, potentially improving the success rate of cancer medicines. Researchers are using this approach to streamline the drug discovery process, reducing costs and side effects.
A study of 67 transplant patients found those with naturally high levels of HLA-G dimer, a powerful immune molecule package, had the lowest risk of rejecting their transplanted kidney. High HLA-G levels also correlated with lower inflammation and higher expression of HLA-G receptors.
Biologists have identified a crucial outer shield on T-type channels that influences the electrochemical signaling of heart and brain cells. This finding holds promise for developing new drugs to treat epilepsy, cardiovascular disease, and cancer by targeting this regulator.
Researchers at Drexel University have created a method for 3D printing living cancer tumors using cervical cancer cells and hydrogel substances. This breakthrough technology allows for more accurate modeling of tumor behavior and response to treatment, potentially leading to new paradigms for cancer research and individual therapies.
Researchers have uncovered how cells block mutation-causing activity of junk DNA, a process involving an enzyme called APOBEC3A. This defense mechanism may help explain a long-standing mystery and has potential implications for cancer treatment.
Moffitt Cancer Center's phase 3 study shows CPX-351 leads to higher remission rates compared to standard options in AML, offering a new game-changer for treatment. The innovative drug combination works by maintaining an optimal ratio of cytarabine and daunorubicin inside lipid vesicles.
Researchers at National University of Singapore identify cancer-specific stem cell causing gastric cancer, opening possibility of developing new drugs to treat this disease. They discovered a cancer-specific variant of a cell surface protein, CD44v8-10, marks gastric cancer stem cells but not normal cells.
Researchers at Harvard's Wyss Institute have successfully created DNA nanodevices that can survive the body's immune defenses long enough to perform diagnostic or therapeutic tasks. The devices use a virus-like cloaking strategy to evade the immune system and deliver drugs directly to diseased tissues.
Researchers found that false-positive mammograms have a temporary and limited impact on women's overall health and well-being. The study also showed that women who experience a false positive may actually be more likely to use breast cancer screening in the future.
Researchers at the University of Pittsburgh discovered a malfunction in the molecular 'proofreading' machinery that repairs DNA damage caused by ultraviolet (UV) light. The protein UV-DDB makes stops along the DNA strand and transiently attaches to it, causing a proofreading change in its conformation, preventing repair in damaged areas.
Researchers have discovered a new role for Cullin-5 in killing cancer cells by targeting proteins that drive cell division. The study suggests a possible test to identify responsive patients and develop more effective drugs.
Scientists have identified a molecule called CD61 on the surface of drug-resistant tumors that induces tumor metastasis by enhancing cancer cell properties. The findings suggest that existing drugs can exploit this pathway to reverse drug resistance and re-sensitize tumors.
A pioneering clinical trial will test multiple drugs simultaneously in patients with advanced lung cancer based on their genetic profile. The 'National Lung Matrix' trial aims to provide more personalized treatment options for cancer patients.
Researchers discovered that cancer drugs can eliminate neural inflammation associated with dementia-linked diseases by eradicating microglia, the primary immune cells of the brain. The study found that these cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
Researchers have created nanoparticles that can deliver three or more different chemotherapy drugs to cancer cells, offering new hope for more effective treatments. The particles are designed to release the drugs in response to specific triggering mechanisms, reducing side effects and increasing efficacy.
A 20-year study confirms that moderate to severe obstructive sleep apnea is independently associated with an increased risk of stroke, cancer, and death. The study found that people with severe sleep apnea were four times more likely to die and nearly four times more likely to have a stroke.
Singlet oxygen modifies target molecules through precise location and monitoring its effects on HCN channels in open and closed states. The findings introduce a method for further exploration of singlet oxygen's role in biological processes, including memory, heart rate, pain sensation, and cancer development.
University of Delaware researchers show that routine procedures in handling and processing nanocarrier solutions can alter their size and shape, affecting targeted drug delivery to cancer cells. The study's findings have significant implications for the production, storage, and use of nano-based drug delivery systems.
Researchers identified a new drug, AMPI-109, effective against triple-negative breast cancer by targeting the PTP4A3 oncogene. The study also provided molecular insights into the disease's biology.
Researchers at Johns Hopkins Kimmel Cancer Center have identified SGK1 enzyme as a potential target for treating asthma and boosting the effects of certain cancer therapies. The enzyme's role in regulating immune system T cells suggests that blocking it could inhibit asthma symptoms and enhance cancer treatment.
A team of researchers created a 3D model of cervical cancer cells using 3D printing, mimicking the complex environment of a tumor. The model showed higher proliferation rates and resistance to anti-cancer drugs compared to traditional 2D models.
Researchers at Duke University Medical Center found that cancers with a BRAF gene mutation require copper for tumor growth, leading to potential new treatments using copper-reducing drugs. The study provides hope for patients with melanoma and other BRAF-driven cancers.
A new experimental compound called TTT-3002 has been identified as a potent inhibitor of genetic mutations in cancer cells that cause some forms of treatment-resistant leukemia. In mouse models, the drug eliminated leukemia cells within 10 days and showed activity against FLT3-mutated cells.
A phase II trial of efatutazone with erlotinib failed to improve efficacy in patients with refractory non-small cell lung cancer, but researchers hope to refine future treatments by identifying the right biomarker for individual patients. The study found that fluid retention was a key factor contributing to the lack of success.
Researchers at UC Davis have identified the atomic structure of kinesin-5, a protein essential for mitosis in virtually all eukaryotic cells. The newly discovered structure reveals unique pockets that could be exploited as targets for new anti-cancer drugs.
A Western University study has discovered a unique population of microbes in the female breast associated with cancer risk. The research found that certain types of bacteria, including Proteobacteria, were present in and beside tumors.
A national survey of over 2,500 teens and young adults found a strong association between liking music with alcohol brand references and increased binge drinking. The study suggests that policy interventions targeting these references could help reduce teen alcohol consumption.
Researchers at the University of Southampton found that a combination of cetuximab and chemotherapy was not effective in treating advanced bowel cancer that had spread to the liver. The study, published in The Lancet Oncology, suggests that this treatment approach may even accelerate cancer progression in some cases.
The I-SPY 2 trial found that neratinib-based treatment improved outcomes for women with newly diagnosed, high-risk breast cancer. The adaptive randomization algorithm successfully identified patient subgroups likely to benefit from the regimen.
A new study from Ohio State University found that the NRAS gene produces five different variants, rather than just one original form, which may help improve cancer treatment. The discovery of these variants could lead to the development of more effective drugs targeting the NRAS pathway.
A recent study published in the Proceedings of the National Academy of Sciences found that the intensity difference between an immune response that stimulates cancer and one that kills it may be minimal. This discovery challenges long-held assumptions about the role of the immune system in preventing and killing cancers.
Researchers develop a new strategy to kill bladder cancer cells by attaching gold nanorods to EGFR proteins, which are overexpressed on these cells. The application of low-intensity laser heat the nanorods, killing the cancer cells without harming healthy tissue.
Researchers from the University of California - San Francisco, led by Margaret Tempero, are part of a national 'dream team' working to accelerate treatment and discoveries for pancreatic cancer. The team aims to turn the deadly disease into a treatable one through targeted approaches and collaborative research.
Researchers have found several molecular alterations that drive the cancer, including mutations and epigenetic changes. The study identifies potential new targets for drug treatments, including existing drugs that could block specific mutations.
A new study by Dartmouth researchers found that young people are increasingly influenced by tobacco marketing, with exposure to coupons and websites associated with increased smoking rates. Black and Hispanic youth are disproportionately affected.
Researchers found that recurrent cancers have unique gene mutations sensitive to dasatinib, a promising new treatment option for recurrent head and neck cancers.
Researchers at UPCI discovered that a subset of patients with lobular carcinoma receive less benefit from adjuvant tamoxifen, indicating potential targets for drug therapy. The study suggests a unique signaling pathway regulated by estrogen in lobular carcinoma cells may be exploited in future clinical trials.
Researchers at the University of Pittsburgh Cancer Institute have discovered a combination therapy that overcomes tumor cell resistance to cisplatin, a widely used cancer drug. The therapy, which involves combining a cell replication blocker with cisplatin, induces rapid and synergistic cell death in resistant tumor cells.
Researchers have developed a new drug delivery method that targets cancer cells using nanoballoons encapsulating anti-cancer drugs. The nanoballoons release the drugs when struck by a red laser, limiting interactions with healthy bodily systems and reducing side effects.
SRPK1 acts as a tumor suppressor when abundant and promotes cancer when scarce, according to researchers at UC San Diego. This unexpected dual role is crucial for understanding tumorigenesis in humans.
A study published in Cancer Epidemiology, Biomarkers & Prevention found that women who took clomiphene citrate or gonadotropins for fertility treatment did not have an increased risk of breast cancer over 30 years. However, a small number of women had a higher risk after multiple cycles of these medications.
Physician Emil J Freireich and scientist Jim Allison have been elected as fellows of the American Association for Cancer Research Academy, known for their contributions to cancer treatment and immunotherapy. Their work has driven significant innovation and progress against cancer, leading to improved survival rates for patients.
Researchers at Dartmouth developed a more accurate and safer treatment for pancreatic cancer by analyzing pre-treatment CT scans. The study found that blood volume in tumors is a key predictor of treatment response, making PDT easier, faster, and more effective.
Professor Jerry Adams has been elected a fellow of the American Association for Cancer Research (AACR) Academy for his outstanding contributions to understanding genes that provoke cancer and control cell death. His research has implicated key drivers of cancer development and revealed their role in cancer drug resistance.
A new study found that certain genetic variants, such as ALDH2 and VCAM1, can predict bladder cancer recurrence in patients. These variants can help identify high-risk patients who require more frequent screenings and aggressive treatment, improving quality of life for all bladder cancer patients.
Researchers discovered several novel genetic defects that cause oesophageal squamous carcinoma, a type of aggressive cancer prevalent in Singapore and Southeast Asia. The study provides insight into the molecular basis of this disease and potential new therapies for treatment.
Researchers identified two adult cancer drugs, pemetrexed and gemcitabine, with potential to improve treatment of high-risk childhood brain tumors. The combination doubled life expectancy of mice with human group 3 medulloblastoma, a subtype with the worst prognosis.
Researchers at Einstein College of Medicine made notable advances in understanding and treating cancer, including new discoveries about nerve cells, cancer-causing genes and epigenetics. They will present their work at the AACR Annual Meeting.
A phase 1 trial found ceritinib to be highly effective against both crizotinib-sensitive and resistant tumors with manageable side effects. The study enrolled 130 participants and showed dramatic shrinkage in tumor size and number in around 60% of patients.
Immunotherapy has shown huge potential in treating lung cancer by preventing tumour cells from escaping the immune system. New data on immunocheckpoint regulators such as PD-1 and PD-L1 have resulted in impressive global overall response rates of 20% to 25%.
Researchers are searching for a hepatitis B cure drug using a new assay and partnering with robots to screen thousands of potential candidates. The goal is to find a treatment that can halt the illness, as current drugs only treat it.
A new study has developed a revolutionary new drug called ZL105 that manipulates the body's natural energy systems to attack and shut down cancerous cells. The compound is based on the precious metal iridium and may be ten times more effective in treating various types of cancers.
A study at Dana-Farber Cancer Institute found wide variation in oncologists' attitudes towards offering cancer gene testing, with those having high genomic confidence more likely to prescribe the test. The survey revealed that 42% of doctors approved telling patients about uncertain test results, highlighting concerns about delivering ...
A study of 439,628 veterans found that taking Valproic acid for at least one year lowered the risk of developing head and neck cancer by 34%. Higher doses and longer durations of use provided additional benefits with up to 16,000 new cases potentially prevented annually in the US.
Researchers at Massachusetts General Hospital have identified a path to safer drugs for heart disease and cancer. By analyzing the structure of an extracellular matrix protein and its interaction with an integrin, they have discovered a high-affinity version that can bind strongly without inducing unintended receptor activation.
A novel simulation-based approach has been used to find and evaluate new potential drugs for liver cancer, identifying 101 compounds predicted to prevent cancer growth in most patients. The researchers simulated the effect of over 3,000 antimetabolites on healthy cells to predict their toxic effects.
A multidisciplinary research team has developed a new approach, E2E Clinical Trials, which aims to improve the accuracy of treatment selection by seamlessly transitioning from controlled efficacy trials to real-world effectiveness trials. This continuum will provide better understanding of treatment effects on diverse patient populations.
Researchers at TGen identified the ALK-EML4 gene fusion as the genetic driver of an aggressive type of thyroid cancer. The study's findings suggest that this fusion can be targeted with existing drug crizotinib, offering a new treatment option for patients with radioiodine-resistant aggressive papillary thyroid cancer.